Latka logo
Immunai logo

Immunairevenue & acquisition

Pharma and Biotech SoftwareNew YorkFounded 2019

Immunai was acquired.

Immunai is a Pharma and Biotech Software company based in New York, founded in 2019.

immunai.comLinkedInUpdated Oct 30, 2026
Annual revenue
$39.1M
Dec 2023EST
Owner
Undisclosed
Date not on record
Employees
194
Dec 2023EST

Immunai revenue

Immunai has not published its revenue. Growjo puts it at about $39.1M a year (December 2023).

$0
$10M
$20M
$30M
$0
–
$39.1M
20192020–222023
ReportedEstimateFounded 2019 at $0; every reading has its own bar
As ofRevenueSource
Dec 2023$39.1MESTGrowjo estimate

Who owns Immunai

Another company owns Immunai. The date and price of the deal are not on record.

Immunai CEO, founders & employees

Noam Solomon founded Immunai in 2019 and led it as CEO. Immunai had 194 employees (December 2023, Growjo estimate).

0
50
100
150
153
194
20222023
ReportedEstimateOne figure per year; a reported figure wins over an estimate
All 2 headcount readings, with sources
As ofEmployeesSource
Dec 2023194ESTGrowjo estimate
Dec 2022153ESTGrowjo estimate

Immunai FAQ

What was Immunai's revenue?

Growjo estimates Immunai's revenue at about $39.1M a year (December 2023). The company hasn't published its own figure.

How many employees does Immunai have?

Growjo estimates Immunai's headcount at about 194 (December 2023).

Who founded Immunai?

Noam Solomon founded Immunai in 2019.

How this page is sourced

3 estimates. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Oct 30, 2026Data disclaimerReport a correctionClaim this profileRun Immunai? Join the podcast